Min Lisa A, Castagnoli Francesca, Vogel Wouter V, Vellenga Jisk P, van Griethuysen Joost J M, Lahaye Max J, Maas Monique, Beets Tan Regina G H, Lambregts Doenja M J
Department of Radiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
GROW School for Oncology and Developmental Biology, University of Maastricht, Maastricht, The Netherlands.
Br J Radiol. 2021 Oct 1;94(1126):20201351. doi: 10.1259/bjr.20201351. Epub 2021 Aug 13.
To investigate trends observed in a decade of published research on multimodality PET(/CT)+MR imaging in abdominal oncology, and to explore how these trends are reflected by the use of multimodality imaging performed at our institution.
First, we performed a literature search (2009-2018) including all papers published on the multimodality combination of PET(/CT) and MRI in abdominal oncology. Retrieved papers were categorized according to a structured labelling system, including study design and outcome, cancer and lesion type under investigation and PET-tracer type. Results were analysed using descriptive statistics and evolutions over time were plotted graphically. Second, we performed a descriptive analysis of the numbers of MRI, PET/CT and multimodality PET/CT+MRI combinations (performed within ≤14 days interval) performed during a similar time span at our institution.
Published research papers involving multimodality PET(/CT)+MRI combinations showed an impressive increase in numbers, both for retrospective combinations of PET/CT and MRI, as well as hybrid PET/MRI. Main areas of research included new PET-tracers, visual PET(/CT)+MRI assessment for staging, and (semi-)quantitative analysis of PET-parameters compared to or combined with MRI-parameters as predictive biomarkers. In line with literature, we also observed a vast increase in numbers of multimodality PET/CT+MRI imaging in our institutional data.
The tremendous increase in published literature on multimodality imaging, reflected by our institutional data, shows the continuously growing interest in comprehensive multivariable imaging evaluations to guide oncological practice.
The role of multimodality imaging in oncology is rapidly evolving. This paper summarizes the main applications and recent developments in multimodality imaging, with a specific focus on the combination of PET+MRI in abdominal oncology.
调查十年来已发表的关于腹部肿瘤多模态PET(/CT)+MR成像研究的观察趋势,并探讨这些趋势如何在我们机构进行的多模态成像应用中得到体现。
首先,我们进行了一项文献检索(2009 - 2018年),纳入所有发表的关于PET(/CT)与MRI在腹部肿瘤中的多模态联合应用的论文。检索到的论文根据结构化标签系统进行分类,包括研究设计和结果、所研究的癌症和病变类型以及PET示踪剂类型。结果采用描述性统计进行分析,并绘制随时间的变化图。其次,我们对在我们机构类似时间段内进行的MRI、PET/CT以及多模态PET/CT + MRI联合检查(检查间隔≤14天)的数量进行了描述性分析。
涉及多模态PET(/CT)+MRI联合应用的已发表研究论文数量显著增加,无论是PET/CT与MRI的回顾性联合,还是PET/MRI一体机的应用。主要研究领域包括新型PET示踪剂、用于分期的PET(/CT)+MRI视觉评估,以及与MRI参数相比或与之结合作为预测生物标志物的PET参数的(半)定量分析。与文献一致,我们在机构数据中也观察到多模态PET/CT + MRI成像数量大幅增加。
我们机构的数据反映出,已发表的关于多模态成像的文献数量大幅增加,表明人们对用于指导肿瘤学实践的综合多变量成像评估的兴趣持续增长。
多模态成像在肿瘤学中的作用正在迅速演变。本文总结了多模态成像的主要应用和最新进展,特别关注PET + MRI在腹部肿瘤中的联合应用。